Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026

Advancing FDA-Cleared Phase IIa Parkinson’s Program Targeting Neuroinflammation

Jupiter Neurosciences, Inc. (NASDAQ:JUNS)

JUPITER, FL, UNITED STATES, March 2, 2026 /⁨EINPresswire.com⁩/ — Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical …